-
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.
-
Experiments suggest that bacteria may persist within bladder epithelial cells in a biofilm contained within pods, thus accounting for bacterial persistence manifested as chronic or recurrent urinary tract infection.
-
Randomized trial data suggest that linezolid is superior to vancomycin in the treatment of nosocomial MRSA pneumonia.
-
Difficulties in Diagnosing Intestinal TB; Can Human Betaretroviruses Trigger Autoimmune Disease?; Rifampin and Pyrazinamide No Longer Recommended for Latent TB; Meningitis in Children with Cochlear Implants
-
Affecting virtually every aspect of our health care system, the stunning growth and rapid integration of hospital-based medicine has affected the practice of both medicine and surgery by significantly modifying the delivery of inpatient, outpatient, and subacute care. This article details the history of hospitalists in the United States by defining the practice of hospital medicine and reviewing the evidence extolling its virtues. Although hospital medicine appears here to stay, work must still be done to address a number of current and future issues facing hospitalists and the health care community embracing them.
-
Increase in Blood Glucose Concentration During Antihypertensive
Treatment as a Predictor of Myocardial Infarction; Adverse Drug Events
in Ambulatory Care; Prevention of Hip Fracture by External Hip
Protectors; Rapid MRI vs Radiographs for Patients with Low Back Pain;
Effectiveness of Anticholinergic Drugs Compared with Placebo in the
Treatment of Overactive Bladder; A Randomized Trial of a Low
Carbohydrate Diet for Obesity
-
Nasally Administered Flu Vaccine Comes to United States; Paxil: Not
Recommended for Children; Prilosec Granted OTC Status; Finasteride and
Prostate Cancer; Xolair: First Biologic Agent for Asthma; West Nile
Virus Update; Study Shows COX-2 Inhibitors Appear Safe with Aspirin in
Asthma Patients; Lamictal Approved for Bipolar Disorder
-
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY.
-
The word is getting out about emergency contraception (EC). A just-released national survey reports that two-thirds of women ages 18-44 are aware that there is something a woman can do to prevent pregnancy in the few days following sexual intercourse.
-
Findings from a new Australian study indicate that use of modern, low-dose oral contraceptives (OCs) containing 50 mcg estrogen or less do not appear to appreciably raise the risk of ischemic stroke in healthy women.
